top of page
Search


Interoperability's next frontier: the Individual Access Layer
An Interview with Brendan Keeler, AKA 'Health API Guy' Over the next few years, we all need to be tracking a new and highly active front in Health IT innovation and change: The emergence of an “individual access layer” that lets patients control how their data moves across tools and apps—and all the related healthcare industry ecosystem opportunities and risks that come that new infrastructure. I’m talking about a new class of players, known as Individual Access Services (IA
Amanda Berra
2 hours ago10 min read


The ROI of healthcare quality: Understanding and explaining the cost-savings benefit of higher quality
For so many mission and humanitarian reasons, let's all take it as a given that everyone in healthcare sees value in improving healthcare quality. And that, therefore, tools, services, resources, or process changes that improve quality will also be perceived as valuable and worth investing in. This is true enough; however, in the real world, it often happens that a more detailed quality ROI case has to be made. Both on the buyer (provider, payer) side and on the vendor (tech,
Marina Renton
Dec 9, 20258 min read


What healthcare-related news we're reading this week (November 24)
We don't just write things at Union Healthcare Insight—we are voracious readers, too. Welcome to our first edition of "What we're reading," in which we go around the virtual corridors of Union HQ finding out what healthcare (or healthcare-related) news been catching the eyes of the research team and why it resonated with us. Read on for more. Healthcare (and related) news highlights from this week Brandon Aylward, Research Consultant What's an article that caught your eye in
Eric Fontana
Nov 25, 202511 min read


The national insurers' financial performance in Q3 2025: MLRs continue to worsen even as overall performance is relatively strong
Over the past few weeks, all five national, publicly traded health plans have hosted their third set of earnings calls for the year, sharing their performance from Q3 and their outlook for the remainder of 2025. We make it a point to stay on top of these players’ performance to monitor the health insurance industry’s overall financial position and to see what the data tell us about ongoing demographic shifts, the margin outlook for providers, the real-world/cost implications
Jordan Peterson
Nov 17, 202512 min read


Agentic AI in healthcare in 2025: Separating the near-term use cases from the hype
Agentic AI in healthcare has rapidly become the centerpiece of health tech discussions. We’ve been studying it because it’s an area of rapid growth and advancement—an outlier in this moment in healthcare, when stakeholders across the industry are struggling amidst rising expenses, workforce shortages, and patient experience frustrations. Agentic AI tools are being positioned as a game-changing approach to addressing many of the industry’s biggest challenges, given their state
Marina Renton
Nov 7, 20258 min read


Down on the Upside? Unpacking the current state of vertical consolidation
For years, vertical consolidation has been a mainstay of the insurer playbook—blending payer, provider, pharmacy, and PBM assets into a single, integrated ecosystem designed to drive synergies, provide consistent margin performance, and withstand turbulence to any one part of the business. It’s a strategy that worked remarkably well through the 2010s and early 2020s. We may be reaching a turning point. Recent financial results across all national players —but especially from
Jordan Peterson
Oct 30, 202511 min read


What's next for GLP-1 innovation: A primer on the race reshaping pharma and chronic disease care
Few categories in modern medicine have captured the imagination of patients, physicians, and investors as quickly as GLP-1 receptor agonists (GLP-1s). Originally developed for diabetes management, these drugs, popularized under brand names such as Ozempic, Wegovy, Mounjaro, and Zepbound, are redefining how we think about obesity, metabolic health, and even chronic disease prevention. And increasingly, GLP-1s are no longer just about controlling blood sugar. They have become c
Brandon Aylward
Oct 16, 202510 min read


Revisiting an under-the-radar quality program: Should hospitals take another look at the Patient Safety Organization (PSO) program?
With a new federal measure set to reward hospitals for participating in the Agency for Healthcare Research and Quality's (AHRQ) Patient Safety Organization (PSO) program starting next year—and a fresh government evaluation pushing for tweaks to the program to improve its effectiveness—PSOs have quickly moved from a relatively niche quality program to a potential strategy priority. PSOs play a strategic role by offering legal protections for safety event data and positioning o
Marina Renton
Oct 10, 202511 min read


Are ICHRAs the next 401(k)s? Current trends in employer spending and employer adoption of ICHRAs
Healthcare costs are accelerating faster than anyone predicted, and employers are struggling to keep up. And our team has been having an internal debate about a scenario that seemed unlikely even just a few years ago: could employer-sponsored insurance (ESI) finally be approaching its defined contribution moment—echoing the pension-to-401(k) transition that reshaped retirement benefits a generation ago? Employers have long relied on ESI to attract and retain workers, but risi
Jordan Peterson
Oct 1, 202512 min read


Examining MAHA’s jump into Real World Data (RWD), and what other industry players can learn from it
MAHA's recent strategic plan announced its intent to create a comprehensive real-world data asset to fuel research. However, any desire to move from data source to insight is likely to be more complex than merely acquiring some data. What potential pitfalls could lie ahead and what can other organizations learn from this?
Eric Fontana
Sep 24, 202518 min read


Different players, different games: How healthcare’s various sectors are using AI differently in 2025
All U.S. health systems, hospitals, provider groups, life sciences organizations, and national or regional payers are racing to scale AI....
Chris Loumeau
Sep 12, 20259 min read


What's on the MAHA agenda as of mid-2025: Where it's focused, and what it means for the healthcare industry
When we last wrote about “Make America Healthy Again” (MAHA) earlier this year, the initiative was more of a slogan than a...
Brandon Aylward
Sep 5, 202514 min read
Join our mailing list
Get access to our latest posts
bottom of page
